Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000038594 |
|---|---|
| Receipt number | R000042983 |
| Scientific Title | A prospective observational study of pembrolizumab and chemotherapy for lung cancer patients with interstitial abnormalities |
| Date of disclosure of the study information | 2019/11/21 |
| Last modified on | 2022/06/13 08:00:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/11/15 12:09:19 | ||
| 2 | Update | 2020/05/18 15:18:33 | Recruitment status Date of IRB |
|
| 3 | Update | 2022/06/13 07:59:26 | Recruitment status Last follow-up date |
|
| 4 | Update | 2022/06/13 08:00:45 | Number of participants that the trial has enrolled |